↓ Skip to main content

Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43

Overview of attention for article published in BMC Complementary Medicine and Therapies, November 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
2 X users
facebook
5 Facebook pages

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43
Published in
BMC Complementary Medicine and Therapies, November 2014
DOI 10.1186/1472-6882-14-434
Pubmed ID
Authors

Shuyan Dai, Jingjing Liu, Xiaofei Sun, Ning Wang

Abstract

Ganoderma lucidum (G. lucidum, Reishimax) is an herbal mushroom known to have inhibitory effect on tumor cell growth. However, the molecular mechanisms responsible for its anti-proliferative effects on the ovarian cancer have not been fully elucidated.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Germany 1 2%
Unknown 42 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 20%
Other 8 18%
Student > Master 8 18%
Student > Bachelor 5 11%
Student > Ph. D. Student 3 7%
Other 5 11%
Unknown 6 14%
Readers by discipline Count As %
Medicine and Dentistry 20 45%
Agricultural and Biological Sciences 7 16%
Biochemistry, Genetics and Molecular Biology 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Chemical Engineering 1 2%
Other 4 9%
Unknown 7 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 August 2022.
All research outputs
#12,953,136
of 23,189,371 outputs
Outputs from BMC Complementary Medicine and Therapies
#1,365
of 3,669 outputs
Outputs of similar age
#117,893
of 263,684 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#55
of 137 outputs
Altmetric has tracked 23,189,371 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,669 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,684 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 137 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.